Viatris (VTRS) Cost of Revenue: 2020-2025
Historic Cost of Revenue for Viatris (VTRS) over the last 5 years, with Sep 2025 value amounting to $2.4 billion.
- Viatris' Cost of Revenue rose 4.21% to $2.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $9.0 billion, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $9.1 billion for FY2024, which is 1.42% up from last year.
- Viatris' Cost of Revenue amounted to $2.4 billion in Q3 2025, which was up 6.19% from $2.2 billion recorded in Q2 2025.
- In the past 5 years, Viatris' Cost of Revenue ranged from a high of $3.3 billion in Q1 2021 and a low of $2.1 billion during Q1 2025.
- Over the past 3 years, Viatris' median Cost of Revenue value was $2.3 billion (recorded in 2023), while the average stood at $2.3 billion.
- As far as peak fluctuations go, Viatris' Cost of Revenue skyrocketed by 92.81% in 2021, and later decreased by 26.72% in 2022.
- Quarterly analysis of 5 years shows Viatris' Cost of Revenue stood at $2.8 billion in 2021, then decreased by 6.92% to $2.6 billion in 2022, then decreased by 13.88% to $2.2 billion in 2023, then climbed by 3.23% to $2.3 billion in 2024, then rose by 4.21% to $2.4 billion in 2025.
- Its Cost of Revenue was $2.4 billion in Q3 2025, compared to $2.2 billion in Q2 2025 and $2.1 billion in Q1 2025.